当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析

万孚生物

(300482)

  

流通市值:91.33亿  总市值:99.33亿
流通股本:4.30亿   总股本:4.68亿

万孚生物(300482)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.26亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益556048.30万元,未分配利润348704.36万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产665251.43万元,负债109203.13万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,690,175,392.81,245,654,367.05800,275,782.513,064,809,396.66
营业总成本1,602,538,044.341,069,201,644.31588,132,685.222,433,963,779.68
其他经营收益
营业利润129,743,948207,841,628.6215,606,151.09636,845,288.18
利润总额126,619,723.75204,776,981.39215,017,806.11629,462,610.16
净利润126,434,775.78190,209,871.9190,072,222.04565,215,133.8
每股收益
其他综合收益-66,202.61-37,344.56-27,967.44-27,150,639.65
综合收益总额126,368,573.17190,172,527.34190,044,254.6538,064,494.15
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,275,266,911.173,383,062,415.273,824,674,042.043,785,861,965.8
非流动资产:
非流动资产合计3,377,247,419.333,516,966,307.733,357,871,870.493,368,790,077.33
资产总计6,652,514,330.56,900,028,7237,182,545,912.537,154,652,043.13
流动负债:
流动负债合计421,200,154.01591,777,965.85661,546,113.92821,464,141
非流动负债:
非流动负债合计670,831,132.56680,847,270.15680,776,518.41682,899,896.54
负债合计1,092,031,286.571,272,625,2361,342,322,632.331,504,364,037.54
所有者权益(或股东权益):
归属于母公司股东权益合计5,500,455,052.075,551,415,349.415,743,386,505.555,554,388,042.84
股东权益合计5,560,483,043.935,627,403,4875,840,223,280.25,650,288,005.59
负债和股东权益合计6,652,514,330.56,900,028,7237,182,545,912.537,154,652,043.13
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,790,338,345.831,154,464,589.94557,099,837.332,601,230,864.98
经营活动现金流出小计1,737,629,150.111,210,776,041.2705,887,556.912,239,519,734.12
经营活动产生的现金流量净额52,709,195.72-56,311,451.26-148,787,719.58361,711,130.86
投资活动产生的现金流量:
投资活动现金流入小计3,616,239,150.522,572,611,7441,268,202,362.964,521,693,638.4
投资活动现金流出小计3,908,280,638.892,776,903,133.961,643,899,089.575,538,290,314.65
投资活动产生的现金流量净额-292,041,488.37-204,291,389.96-375,696,726.61-1,016,596,676.25
筹资活动产生的现金流量:
筹资活动现金流入小计4,736,302.253,134,503.782,386,986.95883,364,758.44
筹资活动现金流出小计390,795,827.59230,339,919.71160,000244,286,833.79
筹资活动产生的现金流量净额-386,059,525.34-227,205,415.932,226,986.95639,077,924.65
汇率变动对现金及现金等价物的影响-266,391.73635,699.82237,482.294,332,842.78
现金及现金等价物净增加额-625,658,209.72-487,172,557.33-522,019,976.95-11,474,777.96
期末现金及现金等价物余额202,444,818.93340,930,471.32306,083,051.7828,103,028.65
补充资料:
现金及现金等价物的净增加额--487,172,557.33--11,474,777.96
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,黄翰漾0.210.701.012025-10-28
西南证券杜向阳0.410.700.802025-10-27
中信建投王在存,贺菊颖0.871.031.192025-10-10
华创证券郑辰,李婵娟0.891.051.262025-09-30
开源证券余汝意0.891.041.252025-08-21
TOP↑